期刊
CLINICAL EPIGENETICS
卷 12, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13148-020-00924-3
关键词
Maternal glucose; Maternal hyperglycemia; Gestational diabetes; Maternal insulin; Diabetes mellitus; DNA methylation; Epigenetics; Differentially methylated regions
资金
- Erasmus Medical Center, Rotterdam
- Erasmus University Rotterdam
- Netherlands Organization for Health Research and Development
- Ministry of Health, Welfare, and Sport
- Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO), Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]
- Genetic Laboratory of the Department of Internal Medicine, Erasmus MC
- National Institute of Child and Human Development [R01HD068437]
- European Research Council [ERC-2014-CoG-648916]
- European Union's Horizon 2020 research and innovation programme LifeCycle [733206]
- European Joint Programming Initiative A Healthy Diet for a Healthy Life (JPI HDHL, NutriPROGRAM project, ZonMw the Netherlands) [529051022]
- European Joint Programming Initiative A Healthy Diet for a Healthy Life (Precise project) [P75416]
- Dutch Heart Foundation [2017 T013]
- Dutch Diabetes Foundation [2017.81.002]
- Netherlands Organization for Health Research and Development (NWO, ZonMW) [543003109]
- MRC [MR/S03658X/1] Funding Source: UKRI
Background Intrauterine exposure to a disturbed maternal glucose metabolism is associated with adverse offspring outcomes. DNA methylation is a potential mechanism underlying these associations. We examined whether maternal early-pregnancy glucose and insulin concentrations are associated with newborn DNA methylation. In a population-based prospective cohort study among 935 pregnant women, maternal plasma concentrations of non-fasting glucose and insulin were measured at a median of 13.1 weeks of gestation (95% range 9.4-17.4). DNA methylation was measured using the Infinium HumanMethylation450 BeadChip (Ilumina). We analyzed associations of maternal early-pregnancy glucose and insulin concentrations with single-CpG DNA methylation using robust linear regression models. Differentially methylated regions were analyzed using the dmrff package in R. We stratified the analyses on normal weight versus overweight or obese women. We also performed a look-up of CpGs and differently methylated regions from previous studies to be associated with maternal gestational diabetes, hyperglycemia or hyperinsulinemia, or with type 2 diabetes in adults. Results Maternal early-pregnancy glucose and insulin concentrations were not associated with DNA methylation at single CpGs nor with differentially methylated regions in the total group. In analyses stratified on maternal BMI, maternal early-pregnancy glucose concentrations were associated with DNA methylation at one CpG (cg03617420,XKR6) among normal weight women and at another (cg12081946,IL17D) among overweight or obese women. No stratum-specific associations were found for maternal early-pregnancy insulin concentrations. The two CpGs were not associated with birth weight or childhood glycemic measures (pvalues > 0.1). Maternal early-pregnancy insulin concentrations were associated with one CpG known to be related to adult type 2 diabetes. Enrichment among nominally significant findings in our maternal early-pregnancy glucose concentrations was found for CpGs identified in a previous study on adult type 2 diabetes. Conclusions Maternal early-pregnancy glucose concentrations, but not insulin concentrations, were associated with DNA methylation at one CpG each in the subgroups of normal weight and of overweight or obese women. No associations were present in the full group. The role of these CpGs in mechanisms underlying offspring health outcomes needs further study. Future studies should replicate our results in larger samples with early-pregnancy information on maternal fasting glucose metabolism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据